-+ 0.00%
-+ 0.00%
-+ 0.00%

Autolus Therapeutics FY2026 AUCATZYL net product revenue expected to be more than $150.000M

Benzinga·11/10/2026 12:02:26
Listen to the news

Autolus Therapeutics (NASDAQ:AUTL) FY2026 AUCATZYL net product revenue expected to be more than $150.000M.